Abbott Patent Application for HIV Spurned

4 Jan 2011

The Economic Times reports on how the Mumbai patent office has rejected drug maker Abbott Laboratories’ patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented.Full story here.

Join us to stay updated
and help make lifesaving medicines accessible to all